Aroa Biosurgery Limited (ASX:ARX)
Australia
· Delayed Price · Currency is AUD 0.620
+0.005 (0.81%)
Mar 9, 2026, 3:21 PM AEST
Aroa Biosurgery Revenue
Aroa Biosurgery had revenue of 44.86M NZD in the half year ending September 30, 2025, with 40.75% growth. This brings the company's revenue in the last twelve months to 90.40M, up 18.40% year-over-year. In the fiscal year ending March 31, 2025, Aroa Biosurgery had annual revenue of 84.70M with 22.63% growth.
Revenue (ttm)
90.40M NZD
Revenue Growth
+18.40%
P/S Ratio
2.70
Revenue / Employee
821.83K NZD
Employees
110
Market Cap
214.20M AUD
Revenue Chart
* This company reports financials in NZD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lumos Diagnostics Holdings | 18.31M |
| Epiminder | 648.18K |
| EMVision Medical Devices | 5.43M |
| SomnoMed | 118.50M |
| Cleo Diagnostics | 2.56M |
| PolyNovo | 139.49M |
| Compumedics | 58.49M |
| Anteris Technologies Global | 2.87M |